Cassava Sciences, Inc. - Common Stock (SAVA)
2.2700
0.00 (0.00%)
Cassava Sciences Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases, particularly Alzheimer's disease
The company aims to address unmet medical needs through its proprietary drug candidates, which are designed to enhance cognitive function and address the underlying biology of neurodegeneration. Cassava Sciences conducts rigorous research and clinical trials to advance its therapeutic solutions, with the vision of improving the quality of life for patients and their families affected by these challenging conditions.
Previous Close | 2.270 |
---|---|
Open | - |
Bid | 2.270 |
Ask | 2.300 |
Day's Range | N/A - N/A |
52 Week Range | 2.230 - 42.20 |
Volume | 1,433 |
Market Cap | 95.27M |
PE Ratio (TTM) | -2.580 |
EPS (TTM) | -0.9 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,508,853 |
News & Press Releases
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 9, 2025
RADNOR, PA - February 9, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Via TheNewswire.com · February 9, 2025
![](https://mms.businesswire.com/media/20250207489521/en/1510725/22/Latest_KSF_SEC.jpg)
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 10, 2025 to file lead plaintiff applications in a securities class action lawsuit against Cassava Sciences, Inc. (NasdaqCM: SAVA), if they purchased the Company’s securities between February 7, 2024 and November 24, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Texas.
By Kahn Swick & Foti, LLC · Via Business Wire · February 7, 2025
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 7, 2025
RADNOR, PA - February 7, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Via TheNewswire.com · February 7, 2025
![](https://mms.businesswire.com/media/20250207179338/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Cassava Sciences, Inc. (NASDAQSAVA) between February 7, 2024 and November 24, 2024. Cassava describes itself as a “clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.”
By The Rosen Law Firm, P.A. · Via Business Wire · February 7, 2025
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 5, 2025
RADNOR, PA - February 5, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Via TheNewswire.com · February 5, 2025
![](https://ml.globenewswire.com/media/8628babf-2ea4-4b8a-a60b-260db109bfa2/small/logo-png.png)
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cassava To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · February 4, 2025
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Joint Stock Company Kaspi.kz (NASDAQKSPI), Applied Therapeutics, Inc. NASDAQ:APLTNASDAQAPLT)(NASDAQ: SAVANASDAQSAVA, and MGP Ingredients, Inc. (NASDAQ: MGPINASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · February 3, 2025
![](https://mms.businesswire.com/media/20250203045205/en/2368314/22/KTMC_Icon.jpg)
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
By Kessler Topaz Meltzer & Check, LLP · Via Business Wire · February 3, 2025
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 3, 2025
RADNOR, PA - February 3, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Via TheNewswire.com · February 3, 2025
![](https://ml.globenewswire.com/media/5d514042-8326-4555-8ad7-f6cc765ecfcd/small/bl-new-logo-jpg.jpg)
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
By Bernstein Liebhard LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/8628babf-2ea4-4b8a-a60b-260db109bfa2/small/logo-png.png)
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cassava To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · February 2, 2025
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · February 1, 2025
RADNOR, PA - February 1, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Via TheNewswire.com · February 1, 2025
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 31, 2025
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 30, 2025
RADNOR, PA - January 30, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Via TheNewswire.com · January 30, 2025
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Joint Stock Company Kaspi.kz (NASDAQKSPI), Sun Communities NYSE: SUINYSESUI)(NASDAQ: SAVANASDAQSAVA, and MGP Ingredients, Inc. (NASDAQ: MGPINASDAQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · January 28, 2025
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 28, 2025
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 28, 2025
RADNOR, PA - January 28, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava”) (NASDAQSAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and November 24, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is February 10, 2025.
Via TheNewswire.com · January 28, 2025